破壊的行動障害（DBD）の世界市場 2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Disruptive Behavior Disorders (DBD) Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D005-00300 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、破壊的行動障害（DBD）の世界市場を広く調査・分析し、今後の市場展望をまとめております。破壊的行動障害（DBD）の種類別市場規模（行動障害（CD）、反抗的障害（ODD））、用途別市場規模（病院・診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Eli Lilly、McNeil Pharmaceuticals、Pfizer、Bionomics、Novartis、Chelsea Therapeutics、New River Pharmaceuticals、DURECT、Johnson & Johnson、Sunovion Pharmaceuticals ・地域別グローバル市場分析 2015年-2020年 ・破壊的行動障害（DBD）の北米市場（アメリカ、カナダ、メキシコ） ・破壊的行動障害（DBD）のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・破壊的行動障害（DBD）のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・破壊的行動障害（DBD）の南米市場（ブラジル、アルゼンチン） ・破壊的行動障害（DBD）の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：行動障害（CD）、反抗的障害（ODD） ・用途別分析：病院・診療所、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論

Market Overview
The global Disruptive Behavior Disorders (DBD) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Disruptive Behavior Disorders (DBD) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Disruptive Behavior Disorders (DBD) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Disruptive Behavior Disorders (DBD) market has been segmented into:
Conduct Disorder (CD)
Oppositional Defiant Disorder (ODD)

By Application, Disruptive Behavior Disorders (DBD) has been segmented into:
Hospitals and Clinics
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Disruptive Behavior Disorders (DBD) market presented in the report. This section sheds light on the sales growth of different regional and country-level Disruptive Behavior Disorders (DBD) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Disruptive Behavior Disorders (DBD) market.

The report offers in-depth assessment of the growth and other aspects of the Disruptive Behavior Disorders (DBD) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Disruptive Behavior Disorders (DBD) Market Share Analysis
Disruptive Behavior Disorders (DBD) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Disruptive Behavior Disorders (DBD) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Disruptive Behavior Disorders (DBD) sales, revenue and market share for each player covered in this report.

The major players covered in Disruptive Behavior Disorders (DBD) are:
Eli Lilly
McNeil Pharmaceuticals
Pfizer
Bionomics
Novartis
Chelsea Therapeutics
New River Pharmaceuticals
DURECT
Johnson & Johnson
Sunovion Pharmaceuticals

レポート目次

---

Table of Contents

1 Disruptive Behavior Disorders (DBD) Market Overview
1.1 Product Overview and Scope of Disruptive Behavior Disorders (DBD)
1.2 Classification of Disruptive Behavior Disorders (DBD) by Type
1.2.1 Global Disruptive Behavior Disorders (DBD) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Disruptive Behavior Disorders (DBD) Revenue Market Share by Type in 2019
1.2.3 Conduct Disorder (CD)
1.2.4 Oppositional Defiant Disorder (ODD)
1.3 Global Disruptive Behavior Disorders (DBD) Market by Application
1.3.1 Overview: Global Disruptive Behavior Disorders (DBD) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals and Clinics
1.3.3 Others
1.4 Global Disruptive Behavior Disorders (DBD) Market by Regions
1.4.1 Global Disruptive Behavior Disorders (DBD) Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Disruptive Behavior Disorders (DBD) (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Disruptive Behavior Disorders (DBD) Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Disruptive Behavior Disorders (DBD) Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Disruptive Behavior Disorders (DBD) Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Disruptive Behavior Disorders (DBD) Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Disruptive Behavior Disorders (DBD) Status and Prospect (2015-2025)
2 Company Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Eli Lilly SWOT Analysis
2.1.4 Eli Lilly Product and Services
2.1.5 Eli Lilly Disruptive Behavior Disorders (DBD) Revenue, Gross Margin and Market Share (2018-2019)
2.2 McNeil Pharmaceuticals
2.2.1 McNeil Pharmaceuticals Details
2.2.2 McNeil Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 McNeil Pharmaceuticals SWOT Analysis
2.2.4 McNeil Pharmaceuticals Product and Services
2.2.5 McNeil Pharmaceuticals Disruptive Behavior Disorders (DBD) Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer SWOT Analysis
2.3.4 Pfizer Product and Services
2.3.5 Pfizer Disruptive Behavior Disorders (DBD) Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bionomics
2.4.1 Bionomics Details
2.4.2 Bionomics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bionomics SWOT Analysis
2.4.4 Bionomics Product and Services
2.4.5 Bionomics Disruptive Behavior Disorders (DBD) Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novartis SWOT Analysis
2.5.4 Novartis Product and Services
2.5.5 Novartis Disruptive Behavior Disorders (DBD) Revenue, Gross Margin and Market Share (2018-2019)
2.6 Chelsea Therapeutics
2.6.1 Chelsea Therapeutics Details
2.6.2 Chelsea Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Chelsea Therapeutics SWOT Analysis
2.6.4 Chelsea Therapeutics Product and Services
2.6.5 Chelsea Therapeutics Disruptive Behavior Disorders (DBD) Revenue, Gross Margin and Market Share (2018-2019)
2.7 New River Pharmaceuticals
2.7.1 New River Pharmaceuticals Details
2.7.2 New River Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 New River Pharmaceuticals SWOT Analysis
2.7.4 New River Pharmaceuticals Product and Services
2.7.5 New River Pharmaceuticals Disruptive Behavior Disorders (DBD) Revenue, Gross Margin and Market Share (2018-2019)
2.8 DURECT
2.8.1 DURECT Details
2.8.2 DURECT Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 DURECT SWOT Analysis
2.8.4 DURECT Product and Services
2.8.5 DURECT Disruptive Behavior Disorders (DBD) Revenue, Gross Margin and Market Share (2018-2019)
2.9 Johnson & Johnson
2.9.1 Johnson & Johnson Details
2.9.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Johnson & Johnson SWOT Analysis
2.9.4 Johnson & Johnson Product and Services
2.9.5 Johnson & Johnson Disruptive Behavior Disorders (DBD) Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sunovion Pharmaceuticals
2.10.1 Sunovion Pharmaceuticals Details
2.10.2 Sunovion Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sunovion Pharmaceuticals SWOT Analysis
2.10.4 Sunovion Pharmaceuticals Product and Services
2.10.5 Sunovion Pharmaceuticals Disruptive Behavior Disorders (DBD) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Disruptive Behavior Disorders (DBD) Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Disruptive Behavior Disorders (DBD) Players Market Share
3.2.2 Top 10 Disruptive Behavior Disorders (DBD) Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Disruptive Behavior Disorders (DBD) Revenue and Market Share by Regions
4.2 North America Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
4.3 Europe Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
4.5 South America Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
5 North America Disruptive Behavior Disorders (DBD) Revenue by Countries
5.1 North America Disruptive Behavior Disorders (DBD) Revenue by Countries (2015-2020)
5.2 USA Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
5.3 Canada Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
5.4 Mexico Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
6 Europe Disruptive Behavior Disorders (DBD) Revenue by Countries
6.1 Europe Disruptive Behavior Disorders (DBD) Revenue by Countries (2015-2020)
6.2 Germany Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
6.3 UK Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
6.4 France Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
6.5 Russia Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
6.6 Italy Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Disruptive Behavior Disorders (DBD) Revenue by Countries
7.1 Asia-Pacific Disruptive Behavior Disorders (DBD) Revenue by Countries (2015-2020)
7.2 China Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
7.3 Japan Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
7.4 Korea Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
7.5 India Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
8 South America Disruptive Behavior Disorders (DBD) Revenue by Countries
8.1 South America Disruptive Behavior Disorders (DBD) Revenue by Countries (2015-2020)
8.2 Brazil Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
8.3 Argentina Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Disruptive Behavior Disorders (DBD) by Countries
9.1 Middle East & Africa Disruptive Behavior Disorders (DBD) Revenue by Countries (2015-2020)
9.2 Saudi Arabia Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
9.3 UAE Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
9.4 Egypt Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
9.5 South Africa Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Disruptive Behavior Disorders (DBD) Revenue and Market Share by Type (2015-2020)
10.2 Global Disruptive Behavior Disorders (DBD) Market Forecast by Type (2019-2024)
10.3 Conduct Disorder (CD) Revenue Growth Rate (2015-2025)
10.4 Oppositional Defiant Disorder (ODD) Revenue Growth Rate (2015-2025)
11 Global Disruptive Behavior Disorders (DBD) Market Segment by Application
11.1 Global Disruptive Behavior Disorders (DBD) Revenue Market Share by Application (2015-2020)
11.2 Disruptive Behavior Disorders (DBD) Market Forecast by Application (2019-2024)
11.3 Hospitals and Clinics Revenue Growth (2015-2020)
11.4 Others Revenue Growth (2015-2020)
12 Global Disruptive Behavior Disorders (DBD) Market Size Forecast (2021-2025)
12.1 Global Disruptive Behavior Disorders (DBD) Market Size Forecast (2021-2025)
12.2 Global Disruptive Behavior Disorders (DBD) Market Forecast by Regions (2021-2025)
12.3 North America Disruptive Behavior Disorders (DBD) Revenue Market Forecast (2021-2025)
12.4 Europe Disruptive Behavior Disorders (DBD) Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Disruptive Behavior Disorders (DBD) Revenue Market Forecast (2021-2025)
12.6 South America Disruptive Behavior Disorders (DBD) Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Disruptive Behavior Disorders (DBD) Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Disruptive Behavior Disorders (DBD) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Disruptive Behavior Disorders (DBD) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Disruptive Behavior Disorders (DBD) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Disruptive Behavior Disorders (DBD) Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Eli Lilly Corporate Information, Location and Competitors
Table 6. Eli Lilly Disruptive Behavior Disorders (DBD) Major Business
Table 7. Eli Lilly Disruptive Behavior Disorders (DBD) Total Revenue (USD Million) (2017-2018)
Table 8. Eli Lilly SWOT Analysis
Table 9. Eli Lilly Disruptive Behavior Disorders (DBD) Product and Solutions
Table 10. Eli Lilly Disruptive Behavior Disorders (DBD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. McNeil Pharmaceuticals Corporate Information, Location and Competitors
Table 12. McNeil Pharmaceuticals Disruptive Behavior Disorders (DBD) Major Business
Table 13. McNeil Pharmaceuticals Disruptive Behavior Disorders (DBD) Total Revenue (USD Million) (2018-2019)
Table 14. McNeil Pharmaceuticals SWOT Analysis
Table 15. McNeil Pharmaceuticals Disruptive Behavior Disorders (DBD) Product and Solutions
Table 16. McNeil Pharmaceuticals Disruptive Behavior Disorders (DBD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Pfizer Corporate Information, Location and Competitors
Table 18. Pfizer Disruptive Behavior Disorders (DBD) Major Business
Table 19. Pfizer Disruptive Behavior Disorders (DBD) Total Revenue (USD Million) (2017-2018)
Table 20. Pfizer SWOT Analysis
Table 21. Pfizer Disruptive Behavior Disorders (DBD) Product and Solutions
Table 22. Pfizer Disruptive Behavior Disorders (DBD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Bionomics Corporate Information, Location and Competitors
Table 24. Bionomics Disruptive Behavior Disorders (DBD) Major Business
Table 25. Bionomics Disruptive Behavior Disorders (DBD) Total Revenue (USD Million) (2017-2018)
Table 26. Bionomics SWOT Analysis
Table 27. Bionomics Disruptive Behavior Disorders (DBD) Product and Solutions
Table 28. Bionomics Disruptive Behavior Disorders (DBD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Novartis Corporate Information, Location and Competitors
Table 30. Novartis Disruptive Behavior Disorders (DBD) Major Business
Table 31. Novartis Disruptive Behavior Disorders (DBD) Total Revenue (USD Million) (2017-2018)
Table 32. Novartis SWOT Analysis
Table 33. Novartis Disruptive Behavior Disorders (DBD) Product and Solutions
Table 34. Novartis Disruptive Behavior Disorders (DBD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Chelsea Therapeutics Corporate Information, Location and Competitors
Table 36. Chelsea Therapeutics Disruptive Behavior Disorders (DBD) Major Business
Table 37. Chelsea Therapeutics Disruptive Behavior Disorders (DBD) Total Revenue (USD Million) (2017-2018)
Table 38. Chelsea Therapeutics SWOT Analysis
Table 39. Chelsea Therapeutics Disruptive Behavior Disorders (DBD) Product and Solutions
Table 40. Chelsea Therapeutics Disruptive Behavior Disorders (DBD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. New River Pharmaceuticals Corporate Information, Location and Competitors
Table 42. New River Pharmaceuticals Disruptive Behavior Disorders (DBD) Major Business
Table 43. New River Pharmaceuticals Disruptive Behavior Disorders (DBD) Total Revenue (USD Million) (2017-2018)
Table 44. New River Pharmaceuticals SWOT Analysis
Table 45. New River Pharmaceuticals Disruptive Behavior Disorders (DBD) Product and Solutions
Table 46. New River Pharmaceuticals Disruptive Behavior Disorders (DBD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. DURECT Corporate Information, Location and Competitors
Table 48. DURECT Disruptive Behavior Disorders (DBD) Major Business
Table 49. DURECT Disruptive Behavior Disorders (DBD) Total Revenue (USD Million) (2017-2018)
Table 50. DURECT SWOT Analysis
Table 51. DURECT Disruptive Behavior Disorders (DBD) Product and Solutions
Table 52. DURECT Disruptive Behavior Disorders (DBD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Johnson & Johnson Corporate Information, Location and Competitors
Table 54. Johnson & Johnson Disruptive Behavior Disorders (DBD) Major Business
Table 55. Johnson & Johnson Disruptive Behavior Disorders (DBD) Total Revenue (USD Million) (2017-2018)
Table 56. Johnson & Johnson SWOT Analysis
Table 57. Johnson & Johnson Disruptive Behavior Disorders (DBD) Product and Solutions
Table 58. Johnson & Johnson Disruptive Behavior Disorders (DBD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Sunovion Pharmaceuticals Corporate Information, Location and Competitors
Table 60. Sunovion Pharmaceuticals Disruptive Behavior Disorders (DBD) Major Business
Table 61. Sunovion Pharmaceuticals Disruptive Behavior Disorders (DBD) Total Revenue (USD Million) (2017-2018)
Table 62. Sunovion Pharmaceuticals SWOT Analysis
Table 63. Sunovion Pharmaceuticals Disruptive Behavior Disorders (DBD) Product and Solutions
Table 64. Sunovion Pharmaceuticals Disruptive Behavior Disorders (DBD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Disruptive Behavior Disorders (DBD) Revenue (Million USD) by Players (2015-2020)
Table 66. Global Disruptive Behavior Disorders (DBD) Revenue Share by Players (2015-2020)
Table 67. Global Disruptive Behavior Disorders (DBD) Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Disruptive Behavior Disorders (DBD) Revenue Market Share by Regions (2015-2020)
Table 69. North America Disruptive Behavior Disorders (DBD) Revenue by Countries (2015-2020)
Table 70. North America Disruptive Behavior Disorders (DBD) Revenue Market Share by Countries (2015-2020)
Table 71. Europe Disruptive Behavior Disorders (DBD) Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Disruptive Behavior Disorders (DBD) Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Disruptive Behavior Disorders (DBD) Revenue by Countries (2015-2020)
Table 74. South America Disruptive Behavior Disorders (DBD) Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Disruptive Behavior Disorders (DBD) Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Disruptive Behavior Disorders (DBD) Revenue Market Share by Countries (2015-2020)
Table 77. Global Disruptive Behavior Disorders (DBD) Revenue (Million USD) by Type (2015-2020)
Table 78. Global Disruptive Behavior Disorders (DBD) Revenue Share by Type (2015-2020)
Table 79. Global Disruptive Behavior Disorders (DBD) Revenue Forecast by Type (2021-2025)
Table 80. Global Disruptive Behavior Disorders (DBD) Revenue by Application (2015-2020)
Table 81. Global Disruptive Behavior Disorders (DBD) Revenue Share by Application (2015-2020)
Table 82. Global Disruptive Behavior Disorders (DBD) Revenue Forecast by Application (2021-2025)
Table 83. Global Disruptive Behavior Disorders (DBD) Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Disruptive Behavior Disorders (DBD) Picture
Figure 2. Global Disruptive Behavior Disorders (DBD) Revenue Market Share by Type in 2019
Figure 3. Conduct Disorder (CD) Picture
Figure 4. Oppositional Defiant Disorder (ODD) Picture
Figure 5. Disruptive Behavior Disorders (DBD) Revenue Market Share by Application in 2019
Figure 6. Hospitals and Clinics Picture
Figure 7. Others Picture
Figure 8. Global Disruptive Behavior Disorders (DBD) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Disruptive Behavior Disorders (DBD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Disruptive Behavior Disorders (DBD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Disruptive Behavior Disorders (DBD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Disruptive Behavior Disorders (DBD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Disruptive Behavior Disorders (DBD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Disruptive Behavior Disorders (DBD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Disruptive Behavior Disorders (DBD) Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Disruptive Behavior Disorders (DBD) Revenue Market Share in 2019
Figure 17. Global Top 10 Players Disruptive Behavior Disorders (DBD) Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Disruptive Behavior Disorders (DBD) Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Disruptive Behavior Disorders (DBD) Revenue Market Share by Regions (2015-2020)
Figure 21. Global Disruptive Behavior Disorders (DBD) Revenue Market Share by Regions in 2018
Figure 22. North America Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
Figure 23. Europe Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
Figure 25. South America Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
Figure 27. North America Disruptive Behavior Disorders (DBD) Revenue Market Share by Countries (2015-2020)
Figure 28. North America Disruptive Behavior Disorders (DBD) Revenue Market Share by Countries in 2019
Figure 29. USA Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
Figure 30. Canada Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
Figure 32. Europe Disruptive Behavior Disorders (DBD) Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Disruptive Behavior Disorders (DBD) Revenue Market Share by Countries in 2019
Figure 34. Germany Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
Figure 35. UK Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
Figure 36. France Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
Figure 37. Russia Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
Figure 38. Italy Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Disruptive Behavior Disorders (DBD) Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Disruptive Behavior Disorders (DBD) Revenue Market Share by Countries in 2019
Figure 41. China Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
Figure 42. Japan Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
Figure 43. Korea Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
Figure 44. India Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
Figure 46. South America Disruptive Behavior Disorders (DBD) Revenue Market Share by Countries (2015-2020)
Figure 47. South America Disruptive Behavior Disorders (DBD) Revenue Market Share by Countries in 2019
Figure 48. Brazil Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Disruptive Behavior Disorders (DBD) Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Disruptive Behavior Disorders (DBD) Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
Figure 53. UAE Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2015-2020)
Figure 56. Global Disruptive Behavior Disorders (DBD) Revenue Share by Type (2015-2020)
Figure 57. Global Disruptive Behavior Disorders (DBD) Revenue Share by Type in 2019
Figure 58. Global Disruptive Behavior Disorders (DBD) Market Share Forecast by Type (2021-2025)
Figure 59. Global Conduct Disorder (CD) Revenue Growth Rate (2015-2020)
Figure 60. Global Oppositional Defiant Disorder (ODD) Revenue Growth Rate (2015-2020)
Figure 61. Global Disruptive Behavior Disorders (DBD) Revenue Share by Application (2015-2020)
Figure 62. Global Disruptive Behavior Disorders (DBD) Revenue Share by Application in 2019
Figure 63. Global Disruptive Behavior Disorders (DBD) Market Share Forecast by Application (2021-2025)
Figure 64. Global Hospitals and Clinics Revenue Growth Rate (2015-2020)
Figure 65. Global Others Revenue Growth Rate (2015-2020)
Figure 66. Global Disruptive Behavior Disorders (DBD) Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Disruptive Behavior Disorders (DBD) Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Disruptive Behavior Disorders (DBD) Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Disruptive Behavior Disorders (DBD) Revenue Market Forecast (2021-2025)
Figure 70. Europe Disruptive Behavior Disorders (DBD) Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Disruptive Behavior Disorders (DBD) Revenue Market Forecast (2021-2025)
Figure 72. South America Disruptive Behavior Disorders (DBD) Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Disruptive Behavior Disorders (DBD) Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel

---